Retinopathy Of Prematurity

Description

Retinopathy of prematurity (ROP) is a rare retinal vasoproliferative disorder affecting preterm infants characterized initially by a delay in physiologic retinal vascular development, and subsequently by aberrant angiogenesis in the form of intravitreal neovascularization.

Clinical Features

Phenotypes and symptoms related to Retinopathy Of Prematurity

  • Blindness
  • Small for gestational age
  • Premature birth
  • Abnormality of the retinal vasculature
  • Vitreous hemorrhage
  • Abnormal macular morphology
  • Retinal arteriolar tortuosity
  • Tractional retinal detachment

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Alternative names

Retinopathy Of Prematurity Is also known as retrolental fibroplasia, rop.

Researches and researchers

Doctors, researchs, and experts related to Retinopathy Of Prematurity extracted from public data.

Retinopathy Of Prematurity Experts map



Current Researchs and researchers

  • BERLIN — Pr Christoph BÜHRER

    Investigator of research project - Coordinator of research network

    • Institution/s:
      — Charité - Universitätsmedizin Berlin (CCM)
    • Research area/topic::

      ROPROP: Propranolol for preemptive treatment of threshold retinopathy of prematurity -DE-


  • GÖTEBORG — Pr Ann HELLSTRÖM

    Investigator of research project - Sponsor of clinical trial - Coordinator of research network

    • Institution/s:
      — The Queen Silvia Children's Hospital - Sahlgrenska
      — The Sahlgrenska Academy at University of Gothenburg, Institute of Clinical Sciences, The Queen Silvia Children's Hospital - Sahlgrenska
    • Research area/topic::

      Molecular defence against retinopathy of prematurity: screening, prevention and treatment


  • BERKELEY — Elia DUH

    Investigator of research project

    • Institution/s:
      — University Of California Berkeley
    • Research area/topic::

      Role of nrf2 in retinal vascularization and rop


  • BOSTON — Jayashree KALPATHY-CRAMER

    Investigator of research project

    • Institution/s:
      — Massachusetts General Hospital
    • Research area/topic::

      Automated retinopathy of prematurity classification using machine learning


  • BOSTON — Olaf DAMMANN

    Investigator of research project

    • Institution/s:
      — Tufts University Boston
    • Research area/topic::

      Circulating immune biomarkers and retinopathy of prematurity


  • CINCINNATI — Rashmi HEGDE

    Investigator of research project

    • Institution/s:
      — Cincinnati Childrens Hosp Med Ctr
    • Research area/topic::

      Eya in retinal angiogenesis


  • HOUSTON — John COOKE

    Investigator of research project

    • Institution/s:
      — Methodist Hospital Research Institute
    • Research area/topic::

      The role of the nicotinic cholinergic pathway in retinopathy of prematurity


  • PHILADELPHIA — Gil BINENBAUM

    Investigator of research project

    • Institution/s:
      — Children's Hosp Of Philadelphia
    • Research area/topic::

      Postnatal growth and retinopathy of prematurity (g-rop) studies


  • PHILADELPHIA — Graham QUINN

    Investigator of research project

    • Institution/s:
      — Children's Hosp Of Philadelphia
    • Research area/topic::

      Telemedicine approaches to evaluating acute-phase rop - erop


Retinopathy Of Prematurity Recommended genes panels

Panel Name, Specifity and genes Tested/covered
MitoMet®Plus aCGH Analysis.

By Baylor Miraca Genetics Laboratories (United States).

RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)

View the complete list with 612 more genes
Specificity
1 %
Genes
100 %
LRP5 (OPPG) DNA Sequencing Test.

By Athena Diagnostics Inc (United States).

LRP5
Specificity
100 %
Genes
34 %
LRP5 Idiopathic Osteoporosis (IOP) DNA Sequencing Test.

By Athena Diagnostics Inc (United States).

LRP5
Specificity
100 %
Genes
34 %
Osteogenesis Imperfecta and Genetic Bone Disorders Panel.

By Collagen Diagnostic Laboratory University of Washington (United States).

BMP1, SEC24D, SPARC, TNFRSF11B, WNT1, MBTPS2, SERPINH1, XYLT2, NBAS, IFITM5, SP7, FKBP10, CREB3L1, P3H1, COL1A2, CRTAP, TMEM38B, GORAB, TAPT1, ALPL , (...)

View the complete list with 9 more genes
Specificity
4 %
Genes
34 %
Cystic Diseases of the Liver/Kidney Panel by next-generation sequencing (NGS).

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).

DNAJB11, SEC63, ALG8, DZIP1L, GANAB, LRP5, PKD2, PKHD1, PRKCSH
Specificity
12 %
Genes
34 %
Osteogenesis Imperfecta & Low Bone Mass Disorders Panel.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center (United States).

BMP1, SEC24D, SPARC, WNT1, CASR, SERPINH1, IFITM5, SP7, FKBP10, CREB3L1, P3H1, SLC34A3, COL1A2, CRTAP, TMEM38B, GORAB, DMP1, ENPP1, FGF23, ALPL , (...)

View the complete list with 8 more genes
Specificity
4 %
Genes
34 %
Osteoporosis Pseudoglioma Syndrome.

By Sheffield Diagnostic Genetics Service Sheffield Children's NHS Foundation Trust (United Kingdom).

LRP5
Specificity
100 %
Genes
34 %
Polycystic kidney and liver disease modifier panel.

By Sheffield Diagnostic Genetics Service Sheffield Children's NHS Foundation Trust (United Kingdom).

HNF1B, TSC1, TSC2, UMOD, DNAJB11, SEC61B, SEC61A1, SEC63, ALG8, DZIP1L, GANAB, LRP5, PKD1, PKD2, PKHD1, PRKCSH, REN
Specificity
6 %
Genes
34 %

You can get up to 201 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

ORPHANET Genetic Syndrome Finder

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like VENTRICULAR SEPTAL DEFECT 3; VSD3 PEDIATRIC HEPATOCELLULAR CARCINOMA OLIVER-MCFARLANE SYNDROME; OMCS AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED; APLAID MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53 NEPHROTIC SYNDROME, TYPE 1; NPHS1 STURGE-WEBER SYNDROME